Gösterilen 1 - 2 sonuçlar arası kayıtlar. 2 sonuç. Aranan kelime 'Simón-Campos , JA', Sorgu süresi: 0.02s Sonuçları Daraltın
  1. 1
    Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

    Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a... Yazar: Buckley, C, Simón-Campos , JA, Zhdan, V, Et al.

    Baskı/Yayın Bilgisi 2020
    Journal article
  2. 2
    Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial

    Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial Yazar: Hobbs, FDR, Montgomery, H, Padilla, F, Simón-Campos, JA, Kim, K, Arbetter, D, Padilla, KW, Reddy, VP, Seegobin, S, Streicher, K, Templeton, A, Viani, RM, Johnsson, E, Koh, GCKW, Esser, MT

    Baskı/Yayın Bilgisi 2023
    Journal article

Arama Araçları: